Home
Membership
Get Involved
Conferences
Education
Public Affairs
Publications
Grants
Awards
About Us
Vacancies


Revolutionizing drug discovery with stem cell technology

18—19 January 2010

GlaxoSmithKline, Stevenage, UK



Organizers:
Aaron Chuang (GlaxoSmithKline, USA)
Melanie Welham (University of Bath, UK)
Katy Gearing (GlaxoSmithKline, UK)

Session 1

 

Chair:
Jason Gardner (GSK, UK)
Monday 18 January 2010
09:30 - 11:00 Registration with tea and coffee

11:00 - 11:10
Welcome
11:10 - 12:00
The ground state of pluripotency
Austin Smith (University of Cambridge, UK)
12:00 - 12:40
Therapeutic and research potential of human stem cells
Stephen Minger (GE Healthcare, UK)
12:40 - 13:00
Surface chemical gradients direct the differentiation of kidney stem cells to proximal tubule cells and podocytes
Selected oral communication - Patricia Murray (University of Liverpool, UK)
13:00 - 14:00 Lunch

Session 2

 

Chair:
Melanie Welham (Univeristy of Bath, UK)
Monday 18 January 2010
14:00 - 14:40
A bio-active polymer promotes stem cell derived hepatocyte inducible drug metabolism
David Hay (Scottish Centre for Regenerative Medicine, UK)
14:40 - 15:20
Derivation and utility of cardiomyocytes from human pluripotent stem cells
Chris Denning (University of Nottingham, UK)
15:20 - 15:50 Coffee/tea break

15:50 - 17:20
Finding new solutions to old problems in drug discovery: Can stem cell technologies help and how?
Round table discussion (Julie Holder, Paul Duffy, Julie Kerby)
17:30 - 18:30 Poster session and drinks reception

18:45 Buses to conference dinner

Session 3

 

Chair:
Graeme Milligan (University of Glasgow, UK)
Tuesday 19 January 2010
09:00 - 09:40
High content screening using human embryonic stem (ES) cell lines
Peter Andrews (University of Sheffield, UK)
09:40 - 10:20
3D tissue culture systems for drug development applications
Lars Sundstrom (University of Southampton, UK)
10:20 - 10:40
Live image based screen on glioblastoma stem cells
Selected oral communication - Davide Danovi (University of Cambridge, UK)
10:40 - 11:10 Coffee/tea break

Session 4

 

Chair:
Peter Andrews (University of Sheffield, UK)
Tuesday 19 January 2010
11:10 - 11:50
Pluripotent stem cells for drug discovery and predictive toxicology
Marc Peschanski (I-Stem, France)
11:50 - 12:30
Identification and characterization of small molecule ligands that maintain pluripotency of hESCs
Graeme Milligan (University of Glasgow, UK)
12:30 - 13:30 Lunch

Session 5

 

Chair:
Aaron Chuang (GSK, USA)
Tuesday 19 January 2010
13:30 - 13:50
Platform technology for three-dimensional cell culture enabling enhanced cell growth, differentiation and function
Selected oral communication - Dan Maltman and Eleanor Knight (Durham University, UK)
13:50 - 14:30
Automation-amenable human pluripotent stem cell culture
Lorraine Young (University of Nottingham, UK)
14:30 - 15:20
Stem cells and drug discovery
Ian Wilmut (Scottish Centre for Regenerative Medicine, UK)
15:20 - 15:30
Presentation of the poster prize and closing remarks with Melanie Welham
15:30 Close of meeting